1 / 5

Task Force on Desensitization: Clinical Protocols and Outcomes Analysis

This report presents findings from the Task Force on Desensitization regarding clinical situations where desensitization has been successfully performed. It outlines the specific drugs involved, describes established protocols with references, and provides comprehensive data on the total number of patients across various drug groups and the total instances of desensitization processes. Additionally, it assesses outcomes and their measurement methods, alongside any concurrent in vitro analyses that were conducted. The report aims to standardize desensitization protocols by recommending an Excel-based registry for better data management.

aiko-stark
Download Presentation

Task Force on Desensitization: Clinical Protocols and Outcomes Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Task Force on Desensitization • Preliminary Questionnaire • In which clinical situations have desensitization been performed • To which drugs? • Which protocol (reference/s)? • Total number of patients in each drug group • Total number of desensitizations (for each drug group) • Outcomes / how they have been measured? • Simultaneous in vitro analysis have bee done?

  2. Task Force on Desensitization

  3. Task Force on Desensitization

  4. Task Force on Desensitization

  5. Task Force on Desensitization • Proposal • Register desensitization protocols in EXCEL program • Main disease • Concomitant diseases • Drug • Initial dose • Route of administration • Interval • Cumulative dose • Continuous • Intermittent • Outcomes • Protocol reference(s)

More Related